Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEP005 0.05% Gel for SCCIS (Bowen's Disease)
NCT00329121Phase 2Completed
- Sponsor
- Peplin
- Start
- May 2006
- Primary completion
- Dec 2006
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ingenol mebutate in squamous cell carcinoma (SCC), sponsored by Peplin. Started May 2006; status: completed.
02
Drugs
ingenol mebutate
03
Conditions
squamous cell carcinoma (SCC)
Beyond the preview
Go deeper on NCT00329121.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00329121.